HU Zhichao 1 # , GE Lida 2 # , LIU Tao 3 , ZHONG Lidan 1,3,4
  • 1. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, 999077, P.R.China;
  • 2. Department of Hepatobiliary Surgery, the First People's Hospital of Xiaoshan District, Hangzhou, Zhejiang Province, Hangzhou, 311200, P.R.China;
  • 3. Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, P.R.China;
  • 4. Hong Kong Chinese Medicine Clinical Study Center, Hong Kong Baptist University, Hong Kong, 999077, P.R.China;
ZHONG Lidan, Email: ldzhong@hkbu.edu.hk
Export PDF Favorites Scan Get Citation

Real-world studies (RWSs) data are based on real medical scenes and reflect clinical facts. Besides, RWSs adapts to the characteristics of therapeutic principles of traditional Chinese medicine and the medical reality of the combination of Western and traditional Chinese medicine, which makes the safety assessment of herb-drug interaction more efficient and economical. During RWSs, more attention should be paid on the validity and reliability of data, especially the standardization of the data collection process and its contents. The safety assessment of herb-drug interaction will combine the methods of active surveillance study, big data analysis, and be based on precision medicine in the future

Citation: HU Zhichao, GE Lida, LIU Tao, ZHONG Lidan. How to focus on the safety assessment of herb-drug interaction in real world studies. Chinese Journal of Evidence-Based Medicine, 2018, 18(11): 1158-1162. doi: 10.7507/1672-2531.201805045 Copy

  • Previous Article

    Study on the reporting standard system of clinical research of traditional Chinese medicine
  • Next Article

    Evaluation and thinking of simulation effect of placebo on new drug clinical trials of traditional Chinese medicines